During the past decade, Aeroallergy Research Laboratories of Savannah, Inc conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aeroallergy Research Laboratories of Savannah, Inc" #1 sponsor was "Sunovion" with 5 trials, followed by "Meda Pharmaceuticals" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aeroallergy Research Laboratories of Savannah, Inc" #1 collaborator was "Covance" with 1 trials as a collaborator, "Innovaderm Research" with 1 trials as a collaborator and "Synteract, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Aeroallergy Research Laboratories of Savannah, Inc" are "Asthma" (7 trials), "Atopic Dermatitis" (5 trials), "Seasonal Allergic Rhinitis" (4 trials), "Perennial Allergic Rhinitis" (2 trials) and "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials). Many other conditions were trialed in "Aeroallergy Research Laboratories of Savannah, Inc" in a lesser frequency.

Most popular intervention types in "Aeroallergy Research Laboratories of Savannah, Inc" are "Drug" (18 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ciclesonide nasal aerosol 37 mcg" (2 trials), "Omalizumab" (2 trials), "Vehicle Cream" (2 trials) and "ciclesonide nasal aerosol 74 mcg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aeroallergy Research Laboratories of Savannah, Inc" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aeroallergy Research Laboratories of Savannah, Inc". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Aeroallergy Research Laboratories of Savannah, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aeroallergy Research Laboratories of Savannah, Inc, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".